Variant report
Variant | nsv873796 |
---|---|
Chromosome Location | chr2:33953186-33981501 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:43)
- CpG islands (count:427)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:43 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr2:33954808-33954914 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr2:33956627-33956689 | K562 | blood: | n/a | n/a |
3 | CTCF | chr2:33964183-33964249 | GM10248 | blood: | n/a | n/a |
4 | CTCF | chr2:33967634-33967691 | GM13976 | blood: | n/a | n/a |
5 | CTCF | chr2:33976115-33976162 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr2:33954600-33954631 | GM13976 | blood: | n/a | n/a |
7 | EBF1 | chr2:33954483-33954634 | GM12878 | blood: | n/a | chr2:33954507-33954518 chr2:33954523-33954534 |
8 | EP300 | chr2:33965205-33965584 | T-47D | breast: | n/a | n/a |
9 | EP300 | chr2:33955388-33955402 | GM12878 | blood: | n/a | n/a |
10 | FOXA1 | chr2:33965143-33965582 | T-47D | breast: | n/a | n/a |
11 | FOXA1 | chr2:33965169-33965564 | T-47D | breast: | n/a | n/a |
12 | GATA3 | chr2:33965164-33965543 | T-47D | breast: | n/a | n/a |
13 | GATA3 | chr2:33965113-33965592 | T-47D | breast: | n/a | n/a |
14 | JUN | chr2:33957684-33957789 | K562 | blood: | n/a | n/a |
15 | MAFF | chr2:33976862-33977068 | HepG2 | liver: | n/a | chr2:33976952-33976970 |
16 | MAFF | chr2:33955908-33956237 | HepG2 | liver: | n/a | chr2:33956091-33956109 chr2:33956090-33956104 |
17 | MAFF | chr2:33955911-33956210 | K562 | blood: | n/a | chr2:33956091-33956109 chr2:33956090-33956104 |
18 | MAFK | chr2:33981191-33981449 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr2:33955910-33956233 | HepG2 | liver: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
20 | MAFK | chr2:33955909-33956239 | IMR90 | lung: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
21 | MAFK | chr2:33955884-33956183 | GM12878 | blood: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
22 | MAFK | chr2:33955909-33956263 | HepG2 | liver: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
23 | MAFK | chr2:33976808-33977109 | HepG2 | liver: | n/a | chr2:33976953-33976968 |
24 | MAFK | chr2:33955771-33956214 | H1-hESC | embryonic stem cell: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
25 | MAFK | chr2:33955914-33956243 | K562 | blood: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
26 | MAFK | chr2:33976838-33977079 | HepG2 | liver: | n/a | chr2:33976953-33976968 |
27 | MAFK | chr2:33981198-33981407 | HepG2 | liver: | n/a | n/a |
28 | MAFK | chr2:33955906-33956220 | Hela-S3 | cervix: | n/a | chr2:33956090-33956104 chr2:33956087-33956107 chr2:33956097-33956108 chr2:33956097-33956108 chr2:33956089-33956105 chr2:33956096-33956107 chr2:33956092-33956107 |
29 | MAFK | chr2:33976859-33977087 | IMR90 | lung: | n/a | chr2:33976953-33976968 |
30 | MAZ | chr2:33955420-33955448 | GM12878 | blood: | n/a | n/a |
31 | MXI1 | chr2:33955456-33955467 | GM12878 | blood: | n/a | n/a |
32 | MXI1 | chr2:33954882-33954999 | GM12878 | blood: | n/a | n/a |
33 | MYC | chr2:33962556-33962693 | HUVEC | blood vessel: | n/a | n/a |
34 | NRF1 | chr2:33954694-33954832 | HepG2 | liver: | n/a | n/a |
35 | POLR2A | chr2:33962228-33962455 | H1-neurons | neurons: | n/a | n/a |
36 | POLR2A | chr2:33974621-33975006 | H1-neurons | neurons: | n/a | n/a |
37 | POLR2A | chr2:33959497-33959654 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr2:33953246-33953295 | GM12878 | blood: | n/a | n/a |
39 | POLR2A | chr2:33955027-33955227 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr2:33972990-33973132 | A549 | lung: | n/a | n/a |
41 | STAT3 | chr2:33976917-33977061 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | TBP | chr2:33954855-33954863 | GM12878 | blood: | n/a | n/a |
43 | ZNF384 | chr2:33958209-33958429 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:33953370-33953420 | NHDF-neo | bronchial: | n/a |
2 | chr2:33953370-33953420 | HRCEpiC | kidney: | n/a |
3 | chr2:33954735-33954785 | A549 | lung: | n/a |
4 | chr2:33953203-33953253 | AoSMC | blood vessel: | n/a |
5 | chr2:33953195-33953245 | PrEC | prostate: | n/a |
6 | chr2:33953203-33953253 | NHBE | bronchial: | n/a |
7 | chr2:33954735-33954785 | T-47D | breast: | n/a |
8 | chr2:33953370-33953420 | GM12892 | blood: | n/a |
9 | chr2:33954043-33954093 | GM12892 | blood: | n/a |
10 | chr2:33953195-33953245 | U87 | brain: | n/a |
11 | chr2:33953370-33953420 | AG09319 | gingival: | n/a |
12 | chr2:33954347-33954397 | HAEpiC | amniotic membrane: | n/a |
13 | chr2:33954735-33954785 | PFSK-1 | brain: | n/a |
14 | chr2:33953370-33953420 | Caco-2 | colon: | n/a |
15 | chr2:33954347-33954397 | HMEC | breast: | n/a |
16 | chr2:33953437-33953487 | LNCaP | prostate: | n/a |
17 | chr2:33953437-33953487 | HCM | heart: | n/a |
18 | chr2:33953203-33953253 | NH-A | brain: | n/a |
19 | chr2:33954347-33954397 | HPAEpiC | pulmonary alveolar: | n/a |
20 | chr2:33954043-33954093 | HL-60 | blood: | n/a |
21 | chr2:33953195-33953245 | IMR90 | lung: | fetal |
22 | chr2:33953195-33953245 | HCF | heart: | n/a |
23 | chr2:33953370-33953420 | HCF | heart: | n/a |
24 | chr2:33953195-33953245 | HCM | heart: | n/a |
25 | chr2:33953203-33953253 | GM12878 | blood: | n/a |
26 | chr2:33953437-33953487 | K562 | blood: | n/a |
27 | chr2:33953195-33953245 | T-47D | breast: | n/a |
28 | chr2:33954347-33954397 | SAEC | small airway: | n/a |
29 | chr2:33954043-33954093 | PrEC | prostate: | n/a |
30 | chr2:33954043-33954093 | Hepatocyte | liver: | n/a |
31 | chr2:33953370-33953420 | HEK293 | kidney: | embryo |
32 | chr2:33953203-33953253 | HL-60 | blood: | n/a |
33 | chr2:33954347-33954397 | HUVEC | blood vessel: | n/a |
34 | chr2:33953195-33953245 | SKMC | muscle: | n/a |
35 | chr2:33954347-33954397 | PrEC | prostate: | n/a |
36 | chr2:33953437-33953487 | HUVEC | blood vessel: | n/a |
37 | chr2:33954735-33954785 | NHDF-neo | bronchial: | n/a |
38 | chr2:33954347-33954397 | BE2_C | brain: | n/a |
39 | chr2:33953437-33953487 | IMR90 | lung: | fetal |
40 | chr2:33953437-33953487 | A549 | lung: | n/a |
41 | chr2:33954735-33954785 | SK-N-SH_RA | brain: | n/a |
42 | chr2:33953437-33953487 | HNPCEpiC | eye: | n/a |
43 | chr2:33954347-33954397 | SK-N-SH | brain: | n/a |
44 | chr2:33954347-33954397 | GM06990 | blood: | n/a |
45 | chr2:33953203-33953253 | BE2_C | brain: | n/a |
46 | chr2:33953370-33953420 | CMK | blood: | n/a |
47 | chr2:33954043-33954093 | H1-hESC | embryonic stem cell: | embryo |
48 | chr2:33953203-33953253 | IMR90 | lung: | fetal |
49 | chr2:33953203-33953253 | H1-hESC | embryonic stem cell: | embryo |
50 | chr2:33954347-33954397 | Jurkat | blood: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MYADML | TF binding region |
MYADML | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7574695 | chr2:33953186-33953187 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs534354077 | chr2:33953194-33953195 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs80084020 | chr2:33953212-33953213 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs538727152 | chr2:33953216-33953217 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs56394321 | chr2:33953220-33953221 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs56879821 | chr2:33953251-33953252 | Inactive region | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs180848357 | chr2:33953276-33953277 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs368565052 | chr2:33953281-33953282 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs541019632 | chr2:33953290-33953291 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs374815980 | chr2:33953370-33953371 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs80037586 | chr2:33953397-33953398 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs78501744 | chr2:33953398-33953399 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs552821667 | chr2:33953468-33953469 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs138043506 | chr2:33954043-33954044 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs75261758 | chr2:33954067-33954068 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs537402945 | chr2:33954093-33954094 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs530522280 | chr2:33954350-33954351 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs576037053 | chr2:33954354-33954355 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs376785122 | chr2:33954380-33954381 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs577488976 | chr2:33954534-33954535 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs140959469 | chr2:33954538-33954539 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs12232965 | chr2:33954560-33954561 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs7585665 | chr2:33954745-33954746 | Inactive region | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs187748717 | chr2:33954747-33954748 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs56268021 | chr2:33954764-33954765 | Inactive region | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs570893631 | chr2:33954767-33954768 | Inactive region | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs192223664 | chr2:33954844-33954845 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs553603204 | chr2:33954845-33954846 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs7585763 | chr2:33954861-33954862 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs78423379 | chr2:33954868-33954869 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs370119795 | chr2:33954898-33954899 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs555586367 | chr2:33954976-33954977 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs556551549 | chr2:33954997-33954998 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs578208890 | chr2:33955008-33955009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6707925 | chr2:33955044-33955045 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs563713799 | chr2:33955062-33955063 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs541700679 | chr2:33955063-33955064 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs185061013 | chr2:33955091-33955092 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs560352957 | chr2:33955115-33955116 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs529178910 | chr2:33955116-33955117 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs144892920 | chr2:33955138-33955139 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs188500506 | chr2:33955139-33955140 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs192126549 | chr2:33955173-33955174 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs559999504 | chr2:33955188-33955189 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs553728951 | chr2:33955191-33955192 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs184173449 | chr2:33955211-33955212 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs77055527 | chr2:33955231-33955232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138753837 | chr2:33955255-33955256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376386416 | chr2:33955294-33955295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535812214 | chr2:33955329-33955330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:33952200-33953200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr2:33952200-33953200 | ZNF genes & repeats | Spleen | Spleen |
3 | chr2:33954800-33955200 | Enhancers | GM12878-XiMat | blood |
4 | chr2:33955000-33955800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr2:33955200-33955600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:33955200-33955800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:33955400-33955800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:33955400-33955800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr2:33955800-33960200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:33960200-33960600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |